Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3040902rdf:typepubmed:Citationlld:pubmed
pubmed-article:3040902lifeskim:mentionsumls-concept:C0205147lld:lifeskim
pubmed-article:3040902lifeskim:mentionsumls-concept:C0020332lld:lifeskim
pubmed-article:3040902lifeskim:mentionsumls-concept:C0005456lld:lifeskim
pubmed-article:3040902lifeskim:mentionsumls-concept:C1704711lld:lifeskim
pubmed-article:3040902lifeskim:mentionsumls-concept:C1510991lld:lifeskim
pubmed-article:3040902pubmed:issue4lld:pubmed
pubmed-article:3040902pubmed:dateCreated1987-10-19lld:pubmed
pubmed-article:3040902pubmed:abstractTextThe distribution of high-affinity binding sites for gamma-[3H]hydroxybutyrate in coronal sections of rat brain was studied by quantitative autoradiographic techniques. Binding sites for this naturally occurring substance, which may possibly have a neurotransmitter role, are concentrated in some restricted areas of the brain, particularly in the limbic system. The hippocampus (especially field CA1 of Ammon's horn, at 292 fmol/mg of tissue), septum (72 fmol/mg of tissue), and cortex (frontal, 113 fmol/mg of tissue; parietal, 103 fmol/mg of tissue; cingulate, 114 fmol/mg of tissue; and entorhinal, 134 fmol/mg of tissue) show pronounced labeling with gamma-[3H]hydroxybutyrate. Binding is much lower in caudatus-putamen (50 fmol/mg of tissue), thalamus, and hypothalamus. Caudal parts of the brain (cerebellum, pons, and medulla) are practically devoid of binding sites. These results strongly support a functional role of endogenous gamma-hydroxybutyrate in particularly restricted areas of the rat brain.lld:pubmed
pubmed-article:3040902pubmed:languageenglld:pubmed
pubmed-article:3040902pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3040902pubmed:citationSubsetIMlld:pubmed
pubmed-article:3040902pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3040902pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3040902pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3040902pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3040902pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3040902pubmed:statusMEDLINElld:pubmed
pubmed-article:3040902pubmed:monthOctlld:pubmed
pubmed-article:3040902pubmed:issn0022-3042lld:pubmed
pubmed-article:3040902pubmed:authorpubmed-author:PujolJ FJFlld:pubmed
pubmed-article:3040902pubmed:authorpubmed-author:MaitreMMlld:pubmed
pubmed-article:3040902pubmed:authorpubmed-author:MachEElld:pubmed
pubmed-article:3040902pubmed:authorpubmed-author:HechlerVVlld:pubmed
pubmed-article:3040902pubmed:authorpubmed-author:WeissmannDDlld:pubmed
pubmed-article:3040902pubmed:issnTypePrintlld:pubmed
pubmed-article:3040902pubmed:volume49lld:pubmed
pubmed-article:3040902pubmed:ownerNLMlld:pubmed
pubmed-article:3040902pubmed:authorsCompleteYlld:pubmed
pubmed-article:3040902pubmed:pagination1025-32lld:pubmed
pubmed-article:3040902pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3040902pubmed:meshHeadingpubmed-meshheading:3040902-...lld:pubmed
pubmed-article:3040902pubmed:meshHeadingpubmed-meshheading:3040902-...lld:pubmed
pubmed-article:3040902pubmed:meshHeadingpubmed-meshheading:3040902-...lld:pubmed
pubmed-article:3040902pubmed:meshHeadingpubmed-meshheading:3040902-...lld:pubmed
pubmed-article:3040902pubmed:meshHeadingpubmed-meshheading:3040902-...lld:pubmed
pubmed-article:3040902pubmed:meshHeadingpubmed-meshheading:3040902-...lld:pubmed
pubmed-article:3040902pubmed:meshHeadingpubmed-meshheading:3040902-...lld:pubmed
pubmed-article:3040902pubmed:meshHeadingpubmed-meshheading:3040902-...lld:pubmed
pubmed-article:3040902pubmed:meshHeadingpubmed-meshheading:3040902-...lld:pubmed
pubmed-article:3040902pubmed:meshHeadingpubmed-meshheading:3040902-...lld:pubmed
pubmed-article:3040902pubmed:meshHeadingpubmed-meshheading:3040902-...lld:pubmed
pubmed-article:3040902pubmed:meshHeadingpubmed-meshheading:3040902-...lld:pubmed
pubmed-article:3040902pubmed:meshHeadingpubmed-meshheading:3040902-...lld:pubmed
pubmed-article:3040902pubmed:meshHeadingpubmed-meshheading:3040902-...lld:pubmed
pubmed-article:3040902pubmed:year1987lld:pubmed
pubmed-article:3040902pubmed:articleTitleRegional distribution of high-affinity gamma-[3H]hydroxybutyrate binding sites as determined by quantitative autoradiography.lld:pubmed
pubmed-article:3040902pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3040902pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3040902lld:pubmed